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Since the discovery of the HLA-A and -B antigens, two questions which have been 
of particular interest are, (a) What is the biological function of these molecules? and 
(b) Why are they the most polymorphic genetic system known in man? The answer to 
these  questions  may be related  because an  understanding  of the  function  of these 
molecules might provide insight into the origins and maintenance of such remarkable 
polymorphism. Until  recently,  the  only known  function  of these  antigens  was  as a 
barrier  to  allogeneic  tissue  transplantation,  which  was  of no  obvious  relevance  to 
individual  survival  during  evolution.  However, studies  in  rodents  (1,  2)  and  more 
recently in humans (3-8) have provided convincing evidence that antigens coded by 
the major histocompatibility complex (MHC) 1 are cell surface structures that play a 
crucial  role  in  immunologic interactions  between  thymus-derived  (T)  lymphocytes 
and other cells. In vitro studies of human cytotoxic T-cell responses have demonstrated 
that  T  cells  must  recognize  foreign  antigen  (such  as  the  male  H-Y  antigen  [3], 
dinitrophenol  [4], and influenza virus [5-8]) in conjunction with cell surface HLA-A 
or -B antigens. This dual requirement  for T-cell activation raises the possibility that 
any individual's response to a particular foreign antigen may be determined not only 
by the molecular properties of the foreign antigen, but also by the repertoire of cell 
surface histocompatibility antigens.  That  this  might account  for the observed poly- 
morphism of MHC genes was proposed by Doherty and Zinkernagel (9). 
The potential evolutionary advantage of HLA-A and -B polymorphism has become 
evident in our studies of HLA-linked genetic control of in vitro cytotoxic responses to 
two closely related human pathogens: type A  and type B influenza viruses. Previous 
studies  have shown  that  in  the  cytotoxic T-cell  response to  type A  influenza  virus 
(A/HK), the viral antigens are recognized in conjunction with self antigens; these self 
antigens are coded by HLA-linked genes (7) and are highly associated with the HLA- 
A  and  -B antigens  (5,  6,  8).  In  addition  to coding  for these  HLA antigens,  HLA- 
linked genes can control the magnitude of cytotoxic responses to virus in conjunction 
with these self antigens (7). Our study extends these observations in parallel studies of 
the cytotoxic response to type B  influenza virus  (B/HK) and demonstrates that the 
1  Abbreviations used in this paper: A/HK, HK-X-31 strain of type A influenza virus; B/HK, HK strain of 
type B influenza virus; E:T, effector:target; MHC, major histocompatihility complex; PBL, peripheral 
blood mononuclear leukocytes. 
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HLA-linked regulation is  virus-specific and  differs  even between these  two  closely 
related viruses. Furthermore, the data indicate that each HLA-A and -B specificity of 
a  given donor may function in the recognition of some but not all foreign antigens. 
Because  MHC-restricted  influenza-specific cytotoxic  effectors  have  been  shown  to 
enhance host survival in mice (10,  11),  the findings presented here for the human T 
cell response may provide a  biologically relevant model by which to account for the 
maintenance of HLA-A and -B polymorphism. 
Materials and Methods 
Human Blood Reagents.  Peripheral blood mononuclear leukocytes  (PBL)  and plasma were 
collected by batch leukapheresis from normal adult volunteers, and the PBL were separated by 
flotation on Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, 
N. J.)  as previously described (12). Plasma from five such male donors was pooled, frozen in 
portions at  -20°C,  and  used  after  thawing as  the  normal plasma  pool.  Fresh  PBL  were 
cryopreserved and  thawed  before  use  as  described  by  Holden et  al.  (13). HLA-A and  -B 
serotyping was  kindly performed  by Dr.  A.  H. Johnson, Duke  University, Durham,  N.  C. 
Family HLA haplotype assignment was made on the basis of the HLA serotyping data for all 
family members and  the  results  of intrafamilial mixed  lymphocyte culture,  as  previously 
described (7). 
Viruses.  A/HK  (A/Hong  Kong/8/68-X-31[H3N2]), and  B/HK  (B/Hong  Kong/8/73), 
were  grown in embryonated eggs  (14), aliquotted, and stored at  -70"C.  Hemagglutination 
titers were measured as described (14). 
Generation of Effectors.  PBL were thawed and resuspended at 3 ×  106/ml in RPMI-1640 with 
glutamine (Grand Island Biological  Co.,  Grand Island, N.  Y.)  supplemented with penicillin 
(100 U/ml) and streptomycin (100 #g/ml). Virus stock was thawed and diluted to a concentra- 
tion of 0.2-2.0 hemagglutination units per milliliter in the same media. 4 ml each of virus 
suspension  and cell suspension  were mixed in tissue culture flasks (Falcon 3013, Falcon Labware, 
Div.  Becton, Dickinson & Co.,  Oxnard, Calif.)  that were  incubated at 37°C in a humidified 
atmosphere of 5% CO2-95% air. After 1 h, 0.5 ml of the normal human plasma pool was added, 
and the flasks were incubated for 7 d. 
Target Cells and Cytotoxicity Assay.  Cytotoxicity was assessed in a standard 6 h ~lCr release 
assay as previously described (15). The targets cells were phytohemagglutinin (M form, Grand 
Island Biological Co.)-stimulated lymphoblasts that were infected with virus on the day of the 
assay (15). 
Data Analysis.  Data from cytotoxicity assays are expressed  as the mean percent specific lysis 
of triplicate determinations (12). Spontaneous release of ~lCr from all target cell preparations 
was <25% of the detergent-releasable counts. To analyze the role of HLA-linked determinants 
in family studies of virus recognition, the effector-target combinations were  subdivided into 
four groups with respect  to the genetic relationship between the effector  and the target:  (a) 
autologous; (b)HLA-identical; (c)HLA-haploidentical; and (d)HLA-different. The mean lysis 
was calculated at each effector:target (E:T) ratio for each group, and the statistical significance 
of differences  was tested by the two-tailed Student's t test. 
Conventional lytic unit calculations were made as follows. Percent specific lysis was plotted 
as a function of the log10 of the effector cell concentration for three different dilutions, and the 
best linear approximation was determined by a least squares fit. The number of cells required 
to generate 30% lysis was determined from the line, and the lyric activity was expressed  as its 
reciprocal. 
Results 
HLA-Linkage of Target Antigens.  We have previously demonstrated in studies of two 
families that human cytotoxic T  cells sensitized against A/HK recognize viral antigens 
in conjunction with  self-determinants that  are  coded  by genes  linked to  HLA  (7). 
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FIG.  1.  HLA restriction  of cytotoxicity  generated  against  B/HK.  In exp.  I,  PBL  from all  nine 
siblings of family B were sensitized in  vitro against  B/HK, and effectors from each sibling were 
assayed on  B/HK-infected target  cells  from seven siblings. Mean  lysis was calculated  at  each of 
three E:T ratios for the seven combinations of effectors on infected autologous targets (&), the  13 
combinations of effectors on HLA-identical targets (Q), the 31  combinations of effectors on HLA- 
haploidentica] targets (~), and the 12 combinations of effectors on HLA-different targets (O). Exp. 
II was similar except that effectors were assayed on infected targets from all  nine siblings. Vertical 
bars designate the standard error of the mean. 
responses to these viruses show little or no cross-reactivity (Table II) (5,  15). Members 
of one of these families (family B)  have been restudied  to analyze the self specificity 
of their cytotoxic responses to B/HK;  the  results  indicate  that  the  response to this 
closely related  virus  is  also restricted  by HLA-linked genes  (Fig.  1).  Mean  lysis of 
HLA-identical target cells was comparable to that observed with autologous targets. 
In contrast,  mean  lysis of HLA-different siblings' targets  was  much  lower  than  of 
either  autologous  or  HLA-identical  targets  (P <  0.001  at  each  E:T  ratio  in  both 
experiments).  In  haploidentical  effector-target combinations  lysis  was  less  than  in 
autologous or HLA-identical combinations but  greater than  in  HLA-different com- 
binations (P <  0.005 in each experiment). Lytic unit calculations indicate that on the 
average 25-50% of the activity on autologous cells is detected on HLA-haploidentical 
targets, and  that  <5%  of the activity is detected  on  HLA-different siblings' targets 
(these conclusions  are independent  of whether  the  lytic unit  calculations  are made 
from the  average data  in  Fig.  1 or made  from the  titrations  of individual  effector 
populations and subsequently averaged). 
Antigen-specific HLA-tinked Genetic Control of Self Specificity.  Previous family studies 
have demonstrated  that  individuals  may generate  a  stronger  cytotoxic response  to 
A/HK  in  conjunction  with  products  of one  HLA  haplotype  than  in  conjunction 
with  the  other  haplotype,  and  that  this  preferential  responsiveness  is  under  HLA- 
linked genetic control  (7).  These studies investigated whether the cytotoxic response 
to B/HK was under similar HLA-linked control, and whether this control resulted in 
the recognition of different self specificities in conjunction with the two closely related 
viruses,  A/HK  and  B/HK.  The  findings  are  illustrated  by  the  data  from  two 
representative experiments with cells from four  HLA-identical siblings  in  family B 
(Fig.  2).  In  each  experiment,  cells  from each  sibling  were stimulated  in  vitro with 
A/HK  and  B/HK,  and  the  effectors were  assayed  to  determine  how  much  of the 
cytotoxic activity for HLA antigens coded by the maternal haplotype (A3 l-B40) and 
how much was specific for HLA antigens coded by the paternal haplotype (A25-B 15). 238  HLA-LINKED VIRUS-SPECIFIC  CONTROL OF CYTOTOXIC RESPONSES 
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FIG. 2.  Virus-specific HLA-linked genetic control of cytotoxic responses to A/HK and B/HK. 
PBL from four HLA-identical siblings of family B were sensitized against either A/HK (upper 
panels) or B/HK (lower panels) and assayed at  three E:T ratios on panels of siblings' targets 
infected with virus of the immunizing strain. For each effector, the bars compare the mean lysis (at 
40:1 E:T ratio) on targets from family members who share only HLA genes of the maternal HLA 
haplotype (HLA-A31-B40) (hatched bars) and the mean lysis on targets who share only HLA genes 
of the paternal HLA haplotype (HLA-A25-B  15) (open bars). Also shown, as a base line, is the mean 
lysis on siblings' targets who are mismatched for both HLA haplotypes (dashed line). 
The three notable features of the results are:  (a)  each of these donor's cells recognizes 
virus  preferentially  in  conjunction  with  products  of one  HLA  haplotype;  (b)  for 
responses to a  given virus,  all  four HLA-identical siblings show the same haplotype 
preference; and (c) for each of these siblings, the haplotype preference in the response 
to  A/HK  is  the  opposite  of that  observed  in  the  response  to  B/HK.  Lytic  unit 
calculations  assist  in  more  accurately  estimating  the  magnitude  of the  haplotype 
preferences observed, and indicate that the differences are quite marked. For example, 
in the  cytotoxic response  to A/HK  in experiment  I, recognition  of products  of the 
paternal haplotype is ~4.7 times greater on the average than recognition of products 
of the maternal haplotype; conversely, in the cytotoxie response to B/HK, there is an 
~2.3-fold difference in the opposite direction (mean haplotype preferences for the four 
siblings were significantly different in responses to the two viruses, P  <  0.002). 
The finding that HLA-identical siblings are similar to one another with respect to 
the  haplotype  preference  in  their  cytotoxic  responses  to  B/HK  suggests  that  this 
preference is controlled by HLA-linked genes. This extends the previous observations 
that  there  is  HLA-linked genetic control of the cytotoxic response to A/HK  among 
members  of this  family  (7).  Moreover,  the  striking  contrast  between  the  haplotype 
preferences observed in  the A/HK  and  B/HK  responses  demonstrates  that  there  is 
antigen specificity in this HLA-linked genetic control, which can result in differences 
in the self specificity of cytotoxic responses to two closely related viruses. 
Virus-Specific Differences m  HLA-A2  Recognition among Unrelated Donors.  Population 
studies also indicate that the repertoire of self determinants  to which cytotoxic T  cells 
respond can be influenced by the immunizing virus. Cells from unrelated  HLA-A2- 
positive donors have been analyzed with respect to cytotoxic T-cell recognition of self 
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TABLE  I 




{-ILA  antigens 
shared 
~11 




Percent  lysis  of target  cells infected with homologous virus* 
UBI7  Sll  H7  UB16  G6  P5  $2  $8  M 
B/HK  2l  25  26  5  7  4  8  6  5 
A/HK  24  32  26  33  29  20  31  42  8 
Auto  Al,2  AI,2  A2  A2  A2  A2  A2 
B7,8  B7,8 
B/HK  27  "i2  33  4  3  1  3  5  3 
A/HK  23  28  29  28  21  16  26  33  9 
AI,2  Auto  AI,2  A2  A2  A2  A2  A2  -- 
B7,8  B7,8 
Figures  denoting autologous lysis  are italicized, and designated  "auto" 
* Indicates targets  infected with virus strain  identical  to the immunizing strain 
Summary of mean percent  lysis 
on targels that are: 
HLA-A 
HLA-A2  ttI,A ntis- 
and -B 
matched  matched 
matched 
25  6  5 
29  31  8 
A1,2  A2 
B7,8 
30  3  3 
26  25  9 
AI,2  A2  -- 
B7,8 
:~ Results  of  HLA-serotyping  on  donors  were  as  follows:  UBI6>A2,3,-Bw35; UBI7:-AI.2,-B7,8; G6:-A2,3,-BI5;  H7:-AI,2,-BT,8;  M:-A3.-Bw35: 
P5:-A2.28.-Bw44: S2:-A2,-BS; SB:-A2,18,-Bw35:  Si I:-AI 2,-B7,13. 
experiment  (Table  I),  cells  from  two  such  donors  failed  to  recognize  HLA-A2  in 
conjunction with B/HK  despite recognition of HLA-A2  in conjunction with A/HK. 
Thus, the results of population studies are consistent with those in the family studies 
that:  (a)  for each donor, some but not all of his HLA specificities may be recognized 
in conjunction with a particular immunizing antigen; and (b) each of a donor's HLA 
specificities may function in cytotoxic responses to some but not all foreign antigens. 
Is the failure to respond to B/HK  in conjunction with HLA-A2 a consistent finding 
with  HLA-A2-positive  donors?  No,  additional  experiments  (Table  II)  confirm  that 
donors  S ll  and  UB17  are  low  responders  to  B/HK  plus  HLA-A2,  and  clearly 
demonstrate that other HLA-A2-positive  donors such as $2 and UB14 are relatively 
high  responders  to  B/HK  plus  HLA-A2.  Although  cells  of donors  UB17  and  S11 
generate strong virus-specific cytotoxicity against autologous cells infected with either 
A/HK  or  B/HK,  the  A/HK  response  is  characterized  by  considerable  HLA-A2- 
restricted  cytotoxic  activity,  whereas  there  is  minimal  HLA-A2-restricted  cytotoxic 
activity generated in the response to B/HK.  (Although in this experiment the overall 
response of these two donors to B/HK  is somewhat less than that to A/HK, lyric unit 
calculations  indicate  that  <1%  of the overall  B/HK  response is HLA-A2  restricted 
compared with ~ 15% of the A/HK  response.) It should be noted that although UB 17 
and Sll  respond poorly to B/HK  in conjunction with HLA-A2  they respond to B/ 
HK  in  conjunction with  HLA-B7  and  -B8  as evidenced  by  lysis of targets  sharing 
those antigens (in addition to HLA-A2). In contrast, cells from UB 14 and $2 generate 
a  strong  HLA-A2-restricted  response  to  both  A/HK  and  B/HK.  The  differences 
between the high responders and the low responders to B/HK  plus HLA-A2 cannot 
be a  result of heterogeneity of the HLA-A2-associated  target  antigen  or inadequate 
viral presentation on the targets cells of the low responders because effectors from the 
high  responders kill the virus-infected  targets from the low responder donors. Thus, 
the ability to evoke a cytotoxic T-ceil response to B/HK  in conjunction with HLA-A2 
is not determined solely by the serologically defined antigens present on the HLA-A2 
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TABLE II 
HLA-A2-Positive  Donors Differ in  Their Cytotoxic  Responses  to B/HK in Conjunction with HLA-A2 
Percent lysis of target cells from indicated donor infected with: 
Effector cell  Immunizing  E:T  Homologous*  Heterologous~ 
donor  virus  Ratio  virus  virus 
UI~14  $2  UB17  Sll  H7  FC4  W5  UBI8  FC4  SI1 
UBI4§  B/HK  40  30  27 
10  21  19 
A/HK  40  45  62 
10  38  49 
HLA antigens shared  Auto  A2 
$2  B/HK  40  24  38 
10  15  27 
A/HK  40  32  56 
I0  16  40 
HLA antigens shared  A2  Auto 
UB  17  B/HK  40  5  8 
10  2  4 
A/HK  40  24  38 
10  9  16 
HLA antigens shared  A2  A2 
Sll  B/HK  40  6  7 
10  3  5 
A/HK  40  20  33 
10  10  14 
HLA antigens shared 
UBI8  B/HK 
A/HK 
HLA antigens shared 
A2  A2 
10  3  4 
10  2  6 
26  27  25  27  31  6 
18  19  16  19  23  2  10  8 
40  47  51  29  59  5 
33  35  38  21  40  3  0  l 
A2  A2  A2  A2  A2  --  A2  A2 
28  31  23  27  29  6 
17  19  12  17  19  0  4  2 
40  44  43  26  53  7 
22  29  29  I6  34  I  0  0 
A2  A2  A2  A2  A2  --  A2  A2 
22  24  21  18  13  20 
15  14  12  11  7  11  4  0 
40  50  51  20  49  26 
30  36  36  I0  30  14  --2  --1 
AI,2  AI,2  A2  A2  A I  A2  A 1,2 
Auto  B7,8  B7,8  B7  B8  B7  B7  B7,8 
30  33  31  17  22  30 
19  21  19  8  13  16  2  0 
38  48  46  18  44  26 
29  33  37  12  28  14  I  2 
AI,2  AI,2  A2  A2  AI  A2 
B7,8  Auto  B7,8  B7  B8  B7  B7  Auto 
29  31  30  28  3  35  4  1 
51  56  61  23  0  48  -I  0 
AI  AI  AI  AI 
B7  B7  B7  B7  --  Auto  B7  B7 
Figures  denoting autologous lysis  are italicized, and designated  "auto." 
* Indicates targets infected with virus strain identical to immunizing strain. 
:~ Indicates  B/HK-infected  targets for A/HK-immune  effectors and vice versa. 
§ Results of HLA-serotyping of donors was as in Table I and also:  UBI4:-A2,-BIS,w44; UBI8:-AI,-B7; FC4:-A2,-B7; W5:A2,-B8. 
Discussion 
The foregoing studies were designed to investigate genetically controlled similarities 
and differences in the cytotoxic responses to two closely related  viruses:  A/HK  and 
B/HK. The results indicate that the in vitro human cytotoxic response to B/HK, like 
the response to A/HK  (5-8), is HLA restricted. Investigation of the genetic regulation 
of these HLA-restricted responses indicates that:  (a) HLA-linked genes can determine 
which of the repertoire of HLA-coded self antigens will be recognized in conjunction 
with particular viral determinants;  (b)  this HLA-linked  regulation is specific  for the 
immunizing virus; and (c) this genetic control in some situations may be a result of a 
regulatory gene distinct  from the HLA-linked gene that codes for the target antigen. 
These  findings  that  HLA-linked  regulation of the cytotoxic response differs  even 
between responses to two closely related viruses (Le., is antigen specific) has important 
implications not only related to possible mechanisms of regulation of T-cell responses 
but  also  related  to  the  evolution  of  HLA  polymorphism.  That  cytotoxic  T-cell 
responses can be beneficial  in  recovery from viral  infections  has been  suggested  by 
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individuals with stronger cytotoxic respones to a particular viral pathogen may have 
a  higher  probability of surviving  an  infection by  that  pathogen.  Thus,  any  viral 
pathogen that has produced significant mortality during evolution may have gener- 
ated a  selective pressure for preservation of host genes that  confer higher cytotoxic 
responses against  that  pathogen.  Independent  of whether influenza virus  itself has 
exerted  a  strong  selective  pressure  in  human  evolution,  the  genetic  mechanisms 
involved in  cytotoxic responses  to  influenza  viruses provide a  model  that  may be 
applicable to human cytotoxic responses to a variety of pathogens. 
A  model to account for the selective advantage of HLA-A and -B polymorphism 
can  be  developed  from  the  following  three  considerations.  First,  available  data 
strongly suggest that products of the HLA-A and -B loci are major self components 
involved in human cytotoxic T-cell recognition of foreign antigens.  Previous studies 
(5-8)  have  demonstrated  that  the  self antigens  recognized  in  conjunction  with 
influenza virus are not only coded by HLA-linked genes, but are very highly associated 
with  HLA-A and  -B  specificities. The  results  in  studies  of other human  cytotoxic 
responses (3, 4) are consistent with recognition of foreign antigens in conjunction with 
HLA-A  and  -B.  Second,  human  cytotoxic  responses  are  often  characterized  by 
preferential recognition of the immunogen in conjunction with some, but not others, 
of the individual's HLA-A and -B antigens (4, 6-8). For example, this study demon- 
strates that the HLA-identical siblings tested responded to B/HK in conjunction with 
products of the HLA-A3 l-B40 haplotype better than in conjunction with products of 
the  HLA-A25-B15  haplotype;  similarly  other  donors  (UB17  and  Sll)  (Table  II) 
reacted  to  B/HK  in  conjunction  with  some  of their  HLA  antigens  but  not  in 
conjunction with HLA-A2. Third, the preferential recognition of HLA target antigens 
is specific for the immunizing virus, as shown in this study. The preferred HLA target 
antigens in a donor's cytotoxic response to B/HK (e.g., products of the HLA-A3 l-B40 
haplotype for siblings 6, 9,  10,  11)  may be different from the preferred HLA target 
antigens  in  that  donor's  response  to  A/HK  (e.g.,  products  of the  HLA-A25-B15 
haplotype for the siblings). 
These  three  observations  suggest  there  would  be  a  selective advantage  for  any 
individual who had more than one specificity of HLA target molecule, because the 
virus-specific strong cytotoxic responses facilitated by each of his HLA antigens would 
compensate for some of the virus-specific deficiencies characteristic of his other HLA 
antigens.  The  finding  described in  this  study  that  there  may be  regulatory genes 
distinct from HLA-A and -B (e.g., regulatory genes accounting for differences between 
donors  in  recognition  of HLA-A2  plus  B/HK)  does  not  invalidate  this  proposed 
explanation of HLA polymorphism; many possible mechanisms of regulatory gene 
function would confer selective advantage of HLA-A and -B heterozygous individuals. 
The simplest example would be a regulatory mechanism that operates by determining 
the T-cell repertoire; if so, there would be genetically determined holes in the T-cell 
repertoire that would result in the failure of T  cells to recognize a particular foreign 
antigen  in  conjunction with  a  given self specificity. Because donors have different 
regulatory genes,  there will be differences between donors in  the specific defects in 
their T-cell repertoires (e.g.,  presence or absence of T  cells that  recognize HLA-A2 
plus B/HK). Regardless of which specific defects there are in an individual's T-cell 
repertoire, HLA heterozygosity would  increase  the  number of possible  contexts in 
which any particular virus would be presented, and thereby decrease the likelihood 242  HLA-LINKED  VIRUS-SPECIFIC CONTROL OF CYTOTOXIC  RESPONSES 
that there would be a total absence of cytotoxic T  cells capable of responding to that 
virus. 
Family studies have demonstrated that the magnitude of HLA-restricted cytotoxic 
responses to influenza viruses are genetically controlled, principally by genes linked to 
HLA (7)  (although preliminary results suggest that in some instances non-HLA genes 
may contribute  to regulation  [W.  E.  Biddison  and  S.  Shaw.  Unpublished  observa- 
tions.]). Where within the HLA complex do these regulatory genes map and by what 
mechanisms do they operate? To simplify subsequent  discussion  of these questions, 
the hypotheses will  be formulated  in  terms of the recognition  of a  particular  HLA 
antigen  (i.e.,  HLA-A2) in conjunction with a specific immunizing virus (i.e.,  B/HK). 
Three general hypotheses will be considered for the location of the regulatory gene(s) 
within the HLA complex, and possible mechanisms of regulation will be proposed for 
each. 
First, recognition of HLA-A2 plus B/HK could be regulated by the structural gene 
that  codes  for  HLA-A2.  For  example,  if  T-cell  responses  require  a  cell  surface 
molecular complex of HLA-A2 and B/HK (altered self)  (1, 2,  16), then the structural 
gene coding for HLA-A2 will determine how well it will form such an immunogenic 
complex. Alternatively, if the generation of a donor's HLA-A2-restricted cytotoxic T- 
cell repertoire is governed by recognition of self HLA-A2 during differentiation in the 
thymus (17,  18), then the HLA-A2 gene acts to regulate the responses by shaping the 
T-cell  repertoire.  Although  there  are  no  data  to  refute  this  hypothesis  that  the 
structural gene is also regulatory, there are data that necessitate postulating either an 
alternative or an additional location for a regulatory gene. Specifically, this hypothesis 
(that  the  HLA-A2  structural  gene  regulates  recognition  of HLA-A2  plus  B/HK) 
cannot  readily explain  why  donors  who  share  HLA-A2 can  differ in  their  B/HK- 
immune T-cell responses  to  HLA-A2  (unless  there  are  differences between  donors' 
HLA-A2 genes that cannot yet be detected serologically or by target cell function in 
cytotoxic T-cell recognition). 
The second possible location for HLA-linked regulatory genes governing recognition 
of HLA-A2 plus B/HK would  be the other HLA-A and  -B genes expressed by the 
donor,  in  analogy  to  the  H-2K-region  control  of H-2D-restricted  cytotoxic  T-cell 
responses in the mouse (19-21).  For example, if the generation of a donor's HLA-A2- 
restricted T-cell repertoire is affected by the presence of other HLA-A and -B gene 
products during thymic differentiation, then those other HLA-A and -B gene products 
would contribute  to regulation of T-cell recognition of HLA-A2 plus B/HK. Alter- 
natively, the response to HLA-A2 plus B/HK might be modulated by a  population 
of regulatory cells specific for B/HK in conjunction  another HLA-A or -B antigen; 
for example, the response to HLA-A2 plus B/HK might be suppressed in a HLA-B7- 
positive donor if he had a high frequency of cytotoxic precursors specific for HLA-B7 
plus B/HK that rapidly eliminated the virus-infected stimulating cells. This second 
hypothesis (that regulation can be a  result of other HLA-A and -B gene products)  is 
consistent  with  the  population  studies  reported  in  this  and  a  previous  study  (8). 
However, preliminary studies  indicate  there are differences in  selective recognition 
among unrelated donors matched for all four HLA-A and -B antigens (W. E. Biddison 
and S. Shaw.  Unpublished observations.); this finding does not rule out either of the 
first two locations considered for regulatory genes, but necessitates postulating either 
an alternative or additional location for a regulatory gene. 
The  third  hypothesis  is  that  the  HLA-linked  regulatory  genes  are  distinct  from s.  SHAW, G. M.  SHEARER, AND W.  E.  BIDDISON  243 
HLA-A and -B and code for products that are not recognized as target antigens by 
virus-immune cytotoxic T  cells.  In analogy to murine studies of/-region control of 
cytotoxic responses to the male H-Y antigen (22, 23), these regulatory genes may map 
to  the  HLA-D  region  and  may  act  by  controlling  helper  and/or  suppressor  cell 
functions. None of the available data excludes this possibility. 
Proposed mechanisms for the HLA-linked genetic regulation must account for the 
fact  that  regulation  is  specific  both  for  the  self HLA  determinant  and  for  the 
immunizing virus. Because donors who fail to recognize B/HK in conjunction with 
HLA-A2 do recognize A/HK  in conjunction  with  HLA-A2, it  is difficult  to argue 
that the defect in B/HK recognition results from inadequate expression of the HLA- 
A2 on the stimulator cell. Similarly, the defect in recognition of HLA-A2 plus B/HK 
cannot reflect a total absence of cytotoxic cells specific for HLA-A2; instead discrete 
subpopulations of cytotoxic lymphocyte precursors specific for both HLA-A2 and B/ 
HK might be absent (or greatly reduced in frequency) in the T-cell repertoire. In any 
case, our observations do not distinguish between a  one-receptor and a  two-receptor 
model  for  the  recognition  of influenza  virus  in  association  with  HLA-coded  self 
products. 
HLA-linked regulation of self-restricted cytotoxic T-cell recognition may be rather 
complex, and may reflect concurrent operation of several of the proposed regulatory 
mechanisms. However, the clear evidence that the regulation is specific for both the 
immunizing  virus  and  for  the  HLA  determinants  may  account  for  the  selective 
advantage of HLA heterozygosity. 
Summary 
The present study compares human cytotoxic T-cell responses to two closely related 
viruses  (type A  and  type B  influenza)  to  understand  the  antigen-specific elements 
involved  in  HLA-linked  genetic  control  of cytotoxic  T-cell  responses.  The  HLA 
antigens function  as self antigens that are recognized by cytotoxic T  cells sensitized 
against either virus.  However, studies in an informative family indicate that  in this 
family,  the  HLA  antigens  preferentially  recognized  in  conjunction  with  type  A 
influenza  (A/HK)  differ from the  HLA antigens  preferentially  recognized  in  con- 
junction  with  type B  influenza  (B/HK).  Similarly, population  studies  demonstrate 
that some (but not all)  donors whose T  cells recognized A/HK  in conjunction with 
HLA-A2 failed to recognize B/HK in conjunction with HLA-A2. Thus, HLA-linked 
regulation  must  operate  by a  mechanism(s)  that  is  specific both  for the  self HLA 
antigen  and  the  viral  antigen.  Furthermore,  these  findings  indicate  that  different 
HLA antigens  may facilitate T-cell responses to different  pathogens,  which  would 
result in an evolutionary advantage for HLA heterozygosity. 
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